We introduce a novel compartmental model accounting for the effects of vaccine efficacy, deployment rates and timing of initiation of deployment. We simulate different scenarios and initial conditions, and we find that higher abundancy and rate of deployment of low efficacy vaccines lowers the cumulative number of deaths in comparison to slower deployment of high efficacy vaccines. We also forecast that, at the same daily deployment rate, the earlier introduction of vaccination schemes with lower efficacy would also lower the number of deaths with respect to a delayed introduction of high efficacy vaccines, which can however, still achieve lower numbers of infections and better herd immunity.
Background: To prevent future outbreaks of COVID-19, Australia is pursuing a mass-vaccination approach in which a targeted group of the population comprising healthcare workers, aged-care residents and other individuals at increased risk of exposure will receive a highly effective priority vaccine. The rest of the population will instead have access to a less effective vaccine. Methods: We apply a large-scale agent-based model of COVID-19 in Australia to investigate the possible implications of this hybrid approach to mass-vaccination. The model is calibrated to recent epidemiological and demo…
Besides maintaining health precautions, vaccination has been the only prevention from SARS-CoV-2, though no clinically proved 100% effective vaccine has been developed till date. At this stage, to withhold the debris of this pandemic, experts need to know the impact of the vaccine efficacy rate's threshold and how long this pandemic may extent with vaccines that have different efficacy rates. In this article, a mathematical model study has been done on the importance of vaccination and vaccine efficiency rate during an ongoing pandemic. We simulated a five compartment mathematical model to ana…
Since the end of 2019, COVID-19 has significantly affected the lives of people around the world. Towards the end of 2020, several COVID-19 vaccine candidates with relatively high efficacy have been reported in the final phase of clinical trials. Vaccines have been considered as critical tools for opening up social and economic activities, thereby lessening the impact of this disease on the society. This paper presents a simulation of COVID-19 spread using modified Susceptible-Infected-Removed (SIR) model under vaccine intervention in several localities of Malaysia, i.e. those cities or states …
A model for cholera with infectiousness of deceased individuals and vaccination
Laboratory L2MIAS, University of N’Djamena（恩贾梅纳大学L2MIAS实验室）；Department of Mathematics, University of Manitoba（曼尼托巴大学数学系）；School of Mathematical and Statistical Sciences, North-West University（西北大学数学与统计科学学院）
With the present highly infectious dominant SARS-CoV-2 strain of B1.1.529 or Omicron spreading around the globe, there is concern that the COVID-19 pandemic will not end soon and that it will be a race against time until a more contagious and virulent variant emerges. One of the most promising approaches for preventing virus propagation is to maintain continuous high vaccination efficacy among the population, thereby strengthening the population protective effect and preventing the majority of infection in the vaccinated population, as is known to occur with the Omicron variant frequently. Cou…
As the development of a dengue vaccine is ongoing, we simulate an hypothetical vaccine as an extra protection to the population. In a first phase, the vaccination process is studied as a new compartment in the model, and different ways of distributing the vaccines investigated: pediatric and random mass vaccines, with distinct levels of efficacy and durability. In a second step, the vaccination is seen as a control variable in the epidemiological process. In both cases, epidemic and endemic scenarios are included in order to analyze distinct outbreak realities.
Since December 2020, variants of COVID-19 (especially Delta and Omicron) appeared with different characteristics that influenced death and transmissibility emerged around the world. To address the novel dynamics of the disease, we propose a dynamical model of two strains, namely native and mutant, transmission dynamics with mutation and imperfect vaccination. It is also assumed that the recuperated individuals from the native strain can be infected with mutant strain through the direct contact with individual or contaminated surfaces or aerosols. We compute the basic reproduction number for ea…
COVID-19 in low-tolerance border quarantine systems: impact of the Delta variant of SARS-CoV-2
The University of Melbourne（墨尔本大学）；Melbourne School of Population and Global Health, The University of Melbourne（墨尔本大学人口与全球健康学院）；The Peter Doherty Institute for Infection and Immunity, The Royal Melbourne Hospital and The University of Melbourne（彼得·多赫蒂感染与免疫研究所、皇家墨尔本医院和墨尔本大学）；Department of Infectious Diseases, The Alfred and Central Clinical School, Monash University（莫纳什大学阿尔弗雷德医院和中央临床学院传染病系）；School of Mathematics and Statistics, The University of Melbourne（墨尔本大学数学与统计学院）
Non-pharmaceutical interventions have been critical in the fight against the COVID-19 pandemic. However, these sanitary measures have been partially lifted due to socioeconomic factors causing a worrisome rebound of the epidemic in several countries. In this work, we assess the effectiveness of the mitigation implemented to constrain the spread of SARS-CoV-2 in the Mexican territory during 2020. We also investigate to what extent the initial deployment of the vaccine will help to mitigate the pandemic and reduce the need for social distancing and other mobility restrictions. Our modeling appro…
An insufficient supply of effective SARS-CoV-2 vaccine in most countries demands an effective vaccination strategy to minimize the damage caused by the disease. Currently, many countries vaccinate their population in descending order of age (i.e. descending order of fatality rate) to minimize the deaths caused by the disease; however, the effectiveness of this strategy needs to be quantitatively assessed. We employ the susceptible-infected-recovered-dead (SIRD) model to investigate various vaccination strategies. We constructed a metapopulation model with heterogeneous contact and fatality rat…
India's mass vaccination efforts have been slow due to high levels of vaccine hesitancy. This study uses data from an online discrete choice experiment with 1371 respondents to rigorously examine the factors shaping vaccine preference in the country. We find that vaccine efficacy, presence of side effects, protection duration, distance to vaccination centre and vaccination rates within social networks play a critical role in determining vaccine demand. We apply a non-parametric model to uncover the heterogeneity in the effects of these factors. We derive two novel insights from this analysis. …
COVID-19 will be a continuous threat to human population despite having a few vaccines at hand until we reach the endemic state through natural herd immunity and total immunization through universal vaccination. However, the vaccine acts as a practical tool for reducing the massive public health problem and the emerging economic consequences that the continuing COVID -19 epidemic is causing worldwide, while the vaccine efficacy wanes. In this work, we propose and analyze an epidemic model of Susceptible-Exposed-Infected-Recovered-Vaccinated (SEIRV) population taking into account the rate of va…
Population heterogeneity, especially in individuals' contact networks, plays an important role in transmission dynamics of infectious diseases. For vaccine-preventable diseases, outstanding issues like vaccine hesitancy and availability of vaccines further lead to nonuniform coverage among groups, not to mention the efficacy of vaccines and the mixing pattern varying from one group to another. As the ongoing COVID-19 pandemic transitions to endemicity, it is of interest and significance to understand the impact of aforementioned population heterogeneity on the emergence and persistence of epid…
Vaccination against COVID-19 with the recently approved mRNA vaccines BNT162b2 (BioNTech/Pfizer) and mRNA-1273 (Moderna) is currently underway in a large number of countries. However, high incidence rates and rapidly spreading SARS-CoV-2 variants are concerning. In combination with acute supply deficits in Europe in early 2021, the question arises of whether stretching the vaccine, for instance by delaying the second dose, can make a significant contribution to preventing deaths, despite associated risks such as lower vaccine efficacy, the potential emergence of escape mutants, enhancement, wa…
In this work, to support decision making of immunisation strategies, we propose the inclusion of two vaccination doses in the SEIR model considering a stochastic cellular automaton. We analyse three different scenarios of vaccination: $i) unlimited doses, (ii) limited doses into susceptible individuals, and (iii) limited doses randomly distributed overall individuals. Our results suggest that the number of vaccinations and time to start the vaccination is more relevant than the vaccine efficacy, delay between the first and second doses, and delay between vaccinated groups. The scenario (i) sho…
